BioNano Genomics, Inc. (BNGO) to Offer Common Stock

BIONANO GENOMICS, INC. (Nasdaq: BNGO), announced today that it plans to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten public offering. There can be no assurance as to whether or when the offering may be completed, or the actual size or terms of the offering. Bionano also expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of shares of common stock offered in the offering, to cover over-allotments, if any. All of the shares in the proposed offering are to be sold by Bionano.

Oppenheimer & Co. Inc. is acting as the sole book-running manager for the offering. BTIG, LLC is acting as the lead manager, and Ladenburg Thalmann & Co. Inc. and Maxim Group LLC are acting as the co-managers.

You May Also Be Interested In

• Nuvectis Pharma prices $100M public offering at $20 per share
• Eco Wave Power raises $4M in direct offering priced at premium
• Biodexa prices $3.5M offering of shares, warrants, and pre-funded warrants